Marico Ltd has set ambitious revenue targets, aiming to achieve ₹15,000 crore by FY27 and ₹20,000 crore by FY30. According to reports from Mint, the consumer goods major is focusing on premium products, packaged foods, and a digital-first strategy to drive this growth. Managing director and CEO Saugata Gupta noted that "adding another ₹5,000 crore over the next three years is a much more achievable task," as the company reshapes its portfolio to focus on new growth areas. The company reported strong FY26 performance with consolidated net profit rising 9.3% to ₹1,813 crore and consolidated revenue from operations growing 26% to ₹13,611 crore. In the current financial year started April, Marico is targeting double-digit revenue growth and aims to cross the ₹150 billion annual revenue threshold while sustaining high single-digit volume growth.
Marico's India volumes surged 8% to a seven-year-high in FY26 and 9% in January-March quarter. As reported by Mint, this robust performance was attributed to a mix of macro and micro factors, including low food inflation encouraging consumers to allocate more wallet share to FMCG products and GST rate cuts that accelerated the shift from unbranded to branded products. The company also benefited from a 35% decline in copra prices from peak levels during the quarter. Gupta noted that premiumization, which draws higher margins, is important for the company, with Marico implementing calibrated price increases of around 7% across certain segments amid rising input costs.
The foods portfolio, including brands like Saffola, True Elements, and Cosmix, is expected to be a key growth lever for Marico. According to Mint, the company's foods business in India has grown fourfold from FY20 to FY24 and now aims to expand the category 15 times by FY30. During the quarter ended March, the foods portfolio registered 16% year-on-growth and exited 2025-26 with more than ₹10 billion revenue. The core Saffola foods portfolio delivered double-digit growth, while Saffola Oats continued to retain its leadership position in the oats market. The company further strengthened its foods portfolio with the acquisition of Cosmix, a leading digital-first functional wellness brand, and 4700 BC, a premium gourmet snacking brand. Gupta noted that 80% of the entire food portfolio is already aligned with the shift toward GLP-1 friendly products, supporting the rising focus on fitness and weight management.
International business emerged as another significant growth driver, with Marico reporting 20% growth in constant currency terms in FY26 - the highest in 14 years. For FY27, the company expects to deliver mid-teen growth in constant currency terms for its global operations, which usually account for over 30% of its top line. Bangladesh, which currently accounts for 45% of international revenue, delivered 35% constant currency revenue growth during the quarter ended March, supported by strong core business and rapid scale-up of new franchises. Vietnam sustained its double-digit revenue growth momentum, recording 18% constant currency growth during the March quarter, while South Africa registered 8% constant currency growth, led by the hair care segment. However, West Asia and North Africa posted decline in constant currency growth for the quarter as the Gulf region was impacted by supply-chain disruptions due to the US-Israel combine's war on Iran.
Marico's shares closed 3% higher at ₹807.20 on the National Stock Exchange on Tuesday, following the company's quarterly results announcement. According to Mint, analysts are optimistic about the company's growth trajectory, with 31 out of 38 analysts tracking the stock having a "buy" or "strongly buy" rating. Motilal Oswal Financial Services noted that given the sustained growth trajectory, diversifying revenue streams, and strong focus on total addressable market expansion, the stock's premium valuation is likely to be sustained. The company's foods and premium personal care portfolio, including digital-first brands, moved up to 23% revenue share this year, with Gupta targeting expansion to 27% by FY27 and one-third by FY30. The company is also making steady progress in premiumising its portfolio across markets, with the premium personal care portfolio exiting FY26 at ₹1,100 crores plus ARR.
